These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2719856)

  • 1. Low-density lipoprotein derived from atherosclerotic patients enhances macrophage cholesterol accumulation and in vitro platelet aggregation.
    Keidar S; Aviram M; Grenadier E; Markiewicz W; Brook JG
    Biochem Med Metab Biol; 1989 Apr; 41(2):117-24. PubMed ID: 2719856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial blood derived low density lipoprotein increases platelet aggregation and macrophage cholesterol content in comparison to lipoprotein derived from veinous blood.
    Keidar S; Aviram M; Grenadier E; Markiewicz W; Brook JG
    Artery; 1989; 16(2):62-71. PubMed ID: 2496679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation.
    Aviram M; Fuhrman B; Keidar S; Maor I; Rosenblat M; Dankner G; Brook G
    J Clin Chem Clin Biochem; 1989 Jan; 27(1):3-12. PubMed ID: 2498457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
    Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
    Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
    Jaakkola O; Solakivi T; Tertov VV; Orekhov AN; Miettinen TA; Nikkari T
    Coron Artery Dis; 1993 Apr; 4(4):379-85. PubMed ID: 8261211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional esterification rate of cholesterol in high density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease.
    Ohta T; Saku K; Takata K; Nagata N; Maung KK; Matsuda I
    Atherosclerosis; 1997 Dec; 135(2):205-12. PubMed ID: 9430370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-modified low-density lipoproteins: studies in normal subjects and in patients with homozygous familial hypercholesterolemia.
    Aviram M
    Clin Biochem; 1987 Apr; 20(2):91-5. PubMed ID: 3608145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages.
    Hoff HF; O'Neil J
    Atherosclerosis; 1988 Mar; 70(1-2):29-41. PubMed ID: 3355615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified forms of low density lipoprotein affect platelet aggregation in vitro.
    Aviram M
    Thromb Res; 1989 Mar; 53(6):561-7. PubMed ID: 2734732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet interaction with high and low density lipoproteins.
    Aviram M; Brook JG
    Atherosclerosis; 1983 Mar; 46(3):259-68. PubMed ID: 6847742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.
    Shmulewitz A; Brook JG; Aviram M
    Biochem J; 1984 Nov; 224(1):13-20. PubMed ID: 6508753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis.
    Baruch Y; Brook JG; Eidelman S; Aviram M
    Atherosclerosis; 1984 Nov; 53(2):151-62. PubMed ID: 6517971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y
    Atherosclerosis; 1999 Jun; 144(2):367-74. PubMed ID: 10407497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein particle uptake and selective uptake of high-density lipoprotein-associated cholesteryl esters by J774 macrophages.
    Rinninger F; Greten H
    Biochim Biophys Acta; 1990 Apr; 1043(3):318-26. PubMed ID: 2157492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoproteins and atherosclerosis.
    Babiak J; Rudel LL
    Baillieres Clin Endocrinol Metab; 1987 Aug; 1(3):515-50. PubMed ID: 3330421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malondialdehyde affects the physico-chemical and biological characteristics of oxidized low density lipoprotein.
    Aviram M
    Atherosclerosis; 1990 Oct; 84(2-3):141-3. PubMed ID: 2282095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
    Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
    Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.